Assessing drug cardiac safety with a 3D engineered cardiac muscle tissue contractility assay platform.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00297
- Awardee
-
Curi Bio Inc. UEI D6VABZ7RVM84
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $63,932
Award facts
- Opportunity
-
- Assessing Drug Cardiac Safety with a 3D Engineered Cardiac Muscle Tissue Contractility Assay Platform Solicitation · 75N95022Q00223 · Posted May 3, 2022
- Contract value 100% obligated
- $63,932.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $63,932 |
Quick answers
Who was awarded contract 75N95022P00297?
75N95022P00297 was awarded to Curi Bio Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 29, 2022.
How much is contract 75N95022P00297 worth?
The government has obligated $63,932 on 75N95022P00297.
Was contract 75N95022P00297 competed?
The extent of competition for 75N95022P00297 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award